A comprehensive view of bayer ag. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
FDA grants fast track designation to Asklepios BioPharmaceutical's AB-1002, a gene therapy for adults with non-ischemic cardiomyopathy and Class III heart failure symptoms; the therapy is currently in Phase 2 trials
Published:
April 18, 2024
by Bayer AG
|
Bayer AG Champions Women's Health, Sustainable Agriculture, and Community Healthcare, Reaching Milestones in Innovation and Inclusivity
Published:
April 18, 2024
by Industry Intelligence Inc.
|
Leaders from Genentech, Bayer, Novo Nordisk, Takeda and others to be keynote speakers at Veeva Commercial Summit; speakers to discuss strategies for effective commercialization and customer engagement
Published:
April 17, 2024
by PR Newswire
|
Bayer AG Lauded for Talent Development in Spain, Advances Hemophilia A Treatments, and Fuels Social Entrepreneurship and Health Data Innovation
Published:
April 17, 2024
by Industry Intelligence Inc.
|
Bayer AG Advances Sustainability and Innovation with Strategic Renewable Energy Partnership and Digital Agriculture Initiatives, Aiming to Support 100 Million in Underserved Communities by 2030
Published:
April 16, 2024
by Industry Intelligence Inc.
|
Ask us about our Health Care Sector market view